Primary small cell carcinoma of the stomach
…, N Yoshikawa, M Kusano, T Yamochi… - Journal of …, 2003 - Wiley Online Library
We report on an 80‐year‐old man with primary gastric small cell carcinoma (SmCC). He was
admitted to hospital with hematemesis. An upper gastrointestinal examination revealed an …
admitted to hospital with hematemesis. An upper gastrointestinal examination revealed an …
CD26 Regulates p38 Mitogen-Activated Protein Kinase–Dependent Phosphorylation of Integrin β1, Adhesion to Extracellular Matrix, and Tumorigenicity of T …
T Sato, T Yamochi, T Yamochi, U Aytac, K Ohnuma… - Cancer research, 2005 - AACR
CD26 is an antigen with key role in T-cell biology and is expressed on selected subsets of
aggressive T-cell malignancies. To elucidate the role of CD26 in tumor behavior, we examine …
aggressive T-cell malignancies. To elucidate the role of CD26 in tumor behavior, we examine …
Deep learning-based automated quantification of goblet cell mucus using histological images as a predictor of clinical relapse of ulcerative colitis with endoscopic …
…, Y Maeda, N Ogata, S Kudo, T Yamochi - Journal of …, 2022 - Springer
Background Mucin depletion is one of the histological indicators of clinical relapse among
patients with ulcerative colitis (UC). Mucin depletion is evaluated semiquantitatively by …
patients with ulcerative colitis (UC). Mucin depletion is evaluated semiquantitatively by …
[HTML][HTML] Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy
…, Y Sasaki, M Homma, T Yamochi… - Oncology …, 2023 - spandidos-publications.com
Immune checkpoint inhibitors (ICIs) are among the most notable advances in cancer
immunotherapy; however, reliable biomarkers for the efficacy of ICIs are yet to be reported. …
immunotherapy; however, reliable biomarkers for the efficacy of ICIs are yet to be reported. …
Molecular differences between sporadic serrated and conventional colorectal adenomas
K Konishi, T Yamochi, R Makino, K Kaneko… - Clinical cancer …, 2004 - AACR
Purpose: The purpose is to compare the molecular characteristics of serrated adenomas (SAs)
with those of conventional adenomas (CADs) and hyperplastic polyps (HPs). …
with those of conventional adenomas (CADs) and hyperplastic polyps (HPs). …
[HTML][HTML] Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative …
…, CK Imamura, S Miura, T Yamochi… - … for Immunotherapy of …, 2023 - ncbi.nlm.nih.gov
Background Hormone receptor (HR)-positive breast cancer is a disease for which no immune
checkpoint inhibitors have shown promise as effective therapies. Cyclin-dependent kinase …
checkpoint inhibitors have shown promise as effective therapies. Cyclin-dependent kinase …
[HTML][HTML] The role of microvessel density, lymph node metastasis, and tumor size as prognostic factors of distant metastasis in colorectal cancer
…, M Omatsu, H Miyachi, T Yamochi… - Oncology …, 2017 - spandidos-publications.com
Angiogenesis is essential for tumor growth and metastasis. CD105 is reportedly a specific
marker for tumor angiogenesis. It has been demonstrated that monoclonal antibodies to …
marker for tumor angiogenesis. It has been demonstrated that monoclonal antibodies to …
Regulation of p38 phosphorylation and topoisomerase IIα expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced …
T Yamochi, T Yamochi, U Aytac, T Sato, K Sato… - Cancer research, 2005 - AACR
CD26 is a M r 110,000 surface-bound glycoprotein with diverse functional properties, including
having a key role in normal T-cell physiology and the development of certain cancers. In …
having a key role in normal T-cell physiology and the development of certain cancers. In …
The GCB subtype of diffuse large B-cell lymphoma is less frequent in Asian countries
E Shiozawa, T Yamochi-Onizuka, M Takimoto, H Ota - Leukemia research, 2007 - Elsevier
Patients with the germinal center B-cell-like (GCB) subtype of diffuse large B-cell lymphoma
(DLBCL) have a significantly better survival rate than those with non-GCB DLBCL. Several …
(DLBCL) have a significantly better survival rate than those with non-GCB DLBCL. Several …
[HTML][HTML] Distinct molecular features of different macroscopic subtypes of colorectal neoplasms
Background Colorectal adenoma develops into cancer with the accumulation of genetic and
epigenetic changes. We studied the underlying molecular and clinicopathological features …
epigenetic changes. We studied the underlying molecular and clinicopathological features …